img

Global Retinal Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Retinal Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat retinal diseases are anticipated to boost the retinal biologics market.
Retinal Biologics report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Retinal Biologics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Retinal Biologics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Retinal Biologics key companies include Spark Therapeutics, Inc, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc, AbbVie Inc, Johnson & Johnson Services, Inc and Amgen Inc, etc. Spark Therapeutics, Inc, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc are top 3 players and held % share in total in 2022.
Retinal Biologics can be divided into Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema and Uveitis, etc. Macular Degeneration is the mainstream product in the market, accounting for % share globally in 2022.
Retinal Biologics is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Retinal Biologics industry development. In 2022, global % share of Retinal Biologics went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Retinal Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Spark Therapeutics, Inc
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc
AbbVie Inc
Johnson & Johnson Services, Inc
Amgen Inc
Segment by Type
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others

Segment by Application


Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Retinal Biologics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Retinal Biologics introduction, etc. Retinal Biologics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Retinal Biologics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Retinal Biologics
1.1 Retinal Biologics Market Overview
1.1.1 Retinal Biologics Product Scope
1.1.2 Retinal Biologics Market Status and Outlook
1.2 Global Retinal Biologics Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Retinal Biologics Market Size by Region (2018-2033)
1.4 Global Retinal Biologics Historic Market Size by Region (2018-2023)
1.5 Global Retinal Biologics Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Retinal Biologics Market Size (2018-2033)
1.6.1 North America Retinal Biologics Market Size (2018-2033)
1.6.2 Europe Retinal Biologics Market Size (2018-2033)
1.6.3 Asia-Pacific Retinal Biologics Market Size (2018-2033)
1.6.4 Latin America Retinal Biologics Market Size (2018-2033)
1.6.5 Middle East & Africa Retinal Biologics Market Size (2018-2033)
2 Retinal Biologics Market by Type
2.1 Introduction
2.1.1 Macular Degeneration
2.1.2 Diabetic Retinopathy
2.1.3 Diabetic Macular Edema
2.1.4 Uveitis
2.1.5 Others
2.2 Global Retinal Biologics Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Retinal Biologics Historic Market Size by Type (2018-2023)
2.2.2 Global Retinal Biologics Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Retinal Biologics Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Retinal Biologics Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Retinal Biologics Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Retinal Biologics Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Retinal Biologics Revenue Breakdown by Type (2018-2033)
3 Retinal Biologics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Retinal Biologics Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Retinal Biologics Historic Market Size by Application (2018-2023)
3.2.2 Global Retinal Biologics Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Retinal Biologics Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Retinal Biologics Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Retinal Biologics Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Retinal Biologics Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Retinal Biologics Revenue Breakdown by Application (2018-2033)
4 Retinal Biologics Competition Analysis by Players
4.1 Global Retinal Biologics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Retinal Biologics as of 2022)
4.3 Date of Key Players Enter into Retinal Biologics Market
4.4 Global Top Players Retinal Biologics Headquarters and Area Served
4.5 Key Players Retinal Biologics Product Solution and Service
4.6 Competitive Status
4.6.1 Retinal Biologics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Spark Therapeutics, Inc
5.1.1 Spark Therapeutics, Inc Profile
5.1.2 Spark Therapeutics, Inc Main Business
5.1.3 Spark Therapeutics, Inc Retinal Biologics Products, Services and Solutions
5.1.4 Spark Therapeutics, Inc Retinal Biologics Revenue (US$ Million) & (2018-2023)
5.1.5 Spark Therapeutics, Inc Recent Developments
5.2 F. Hoffmann-La Roche Ltd
5.2.1 F. Hoffmann-La Roche Ltd Profile
5.2.2 F. Hoffmann-La Roche Ltd Main Business
5.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Ltd Retinal Biologics Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Ltd Recent Developments
5.3 Regeneron Pharmaceuticals, Inc
5.3.1 Regeneron Pharmaceuticals, Inc Profile
5.3.2 Regeneron Pharmaceuticals, Inc Main Business
5.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Products, Services and Solutions
5.3.4 Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue (US$ Million) & (2018-2023)
5.3.5 AbbVie Inc Recent Developments
5.4 AbbVie Inc
5.4.1 AbbVie Inc Profile
5.4.2 AbbVie Inc Main Business
5.4.3 AbbVie Inc Retinal Biologics Products, Services and Solutions
5.4.4 AbbVie Inc Retinal Biologics Revenue (US$ Million) & (2018-2023)
5.4.5 AbbVie Inc Recent Developments
5.5 Johnson & Johnson Services, Inc
5.5.1 Johnson & Johnson Services, Inc Profile
5.5.2 Johnson & Johnson Services, Inc Main Business
5.5.3 Johnson & Johnson Services, Inc Retinal Biologics Products, Services and Solutions
5.5.4 Johnson & Johnson Services, Inc Retinal Biologics Revenue (US$ Million) & (2018-2023)
5.5.5 Johnson & Johnson Services, Inc Recent Developments
5.6 Amgen Inc
5.6.1 Amgen Inc Profile
5.6.2 Amgen Inc Main Business
5.6.3 Amgen Inc Retinal Biologics Products, Services and Solutions
5.6.4 Amgen Inc Retinal Biologics Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Inc Recent Developments
6 North America
6.1 North America Retinal Biologics Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Retinal Biologics Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Retinal Biologics Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Retinal Biologics Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Retinal Biologics Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Retinal Biologics Market Dynamics
11.1 Retinal Biologics Industry Trends
11.2 Retinal Biologics Market Drivers
11.3 Retinal Biologics Market Challenges
11.4 Retinal Biologics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Retinal Biologics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Retinal Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Retinal Biologics Market Size Share by Region (2018-2023)
Table 4. Global Retinal Biologics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Retinal Biologics Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Retinal Biologics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Retinal Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Retinal Biologics Revenue Market Share by Type (2018-2023)
Table 9. Global Retinal Biologics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Retinal Biologics Revenue Market Share by Type (2024-2033)
Table 11. North America Retinal Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Retinal Biologics Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Retinal Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Retinal Biologics Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Retinal Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Retinal Biologics Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Retinal Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Retinal Biologics Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Retinal Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Retinal Biologics Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Retinal Biologics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Retinal Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Retinal Biologics Revenue Market Share by Application (2018-2023)
Table 24. Global Retinal Biologics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Retinal Biologics Revenue Market Share by Application (2024-2033)
Table 26. North America Retinal Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Retinal Biologics Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Retinal Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Retinal Biologics Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Retinal Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Retinal Biologics Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Retinal Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Retinal Biologics Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Retinal Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Retinal Biologics Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Retinal Biologics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Retinal Biologics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Retinal Biologics as of 2022)
Table 39. Date of Key Players Enter into Retinal Biologics Market
Table 40. Global Retinal Biologics Key Players Headquarters and Area Served
Table 41. Retinal Biologics Product Solution and Service
Table 42. Global Retinal Biologics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Spark Therapeutics, Inc Basic Information List
Table 45. Spark Therapeutics, Inc Description and Business Overview
Table 46. Spark Therapeutics, Inc Retinal Biologics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Retinal Biologics Business of Spark Therapeutics, Inc (2018-2023)
Table 48. Spark Therapeutics, Inc Recent Developments
Table 49. F. Hoffmann-La Roche Ltd Basic Information List
Table 50. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 51. F. Hoffmann-La Roche Ltd Retinal Biologics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Retinal Biologics Business of F. Hoffmann-La Roche Ltd (2018-2023)
Table 53. F. Hoffmann-La Roche Ltd Recent Developments
Table 54. Regeneron Pharmaceuticals, Inc Basic Information List
Table 55. Regeneron Pharmaceuticals, Inc Description and Business Overview
Table 56. Regeneron Pharmaceuticals, Inc Retinal Biologics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Retinal Biologics Business of Regeneron Pharmaceuticals, Inc (2018-2023)
Table 58. Regeneron Pharmaceuticals, Inc Recent Developments
Table 59. AbbVie Inc Basic Information List
Table 60. AbbVie Inc Description and Business Overview
Table 61. AbbVie Inc Retinal Biologics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Retinal Biologics Business of AbbVie Inc (2018-2023)
Table 63. AbbVie Inc Recent Developments
Table 64. Johnson & Johnson Services, Inc Basic Information List
Table 65. Johnson & Johnson Services, Inc Description and Business Overview
Table 66. Johnson & Johnson Services, Inc Retinal Biologics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Retinal Biologics Business of Johnson & Johnson Services, Inc (2018-2023)
Table 68. Johnson & Johnson Services, Inc Recent Developments
Table 69. Amgen Inc Basic Information List
Table 70. Amgen Inc Description and Business Overview
Table 71. Amgen Inc Retinal Biologics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Retinal Biologics Business of Amgen Inc (2018-2023)
Table 73. Amgen Inc Recent Developments
Table 74. North America Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 75. North America Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 76. Europe Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 77. Europe Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 78. Asia-Pacific Retinal Biologics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 79. Asia-Pacific Retinal Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 80. Asia-Pacific Retinal Biologics Market Size by Region (2024-2033) & (US$ Million)
Table 81. Asia-Pacific Retinal Biologics Market Share by Region (2018-2023)
Table 82. Asia-Pacific Retinal Biologics Market Share by Region (2024-2033)
Table 83. Latin America Retinal Biologics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 84. Latin America Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 85. Latin America Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 86. Middle East & Africa Retinal Biologics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 87. Middle East & Africa Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 88. Middle East & Africa Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 89. Retinal Biologics Market Trends
Table 90. Retinal Biologics Market Drivers
Table 91. Retinal Biologics Market Challenges
Table 92. Retinal Biologics Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Biologics Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Retinal Biologics Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Retinal Biologics Market Share by Regions: 2022 VS 2033
Figure 4. Global Retinal Biologics Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Retinal Biologics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Retinal Biologics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Retinal Biologics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Retinal Biologics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Retinal Biologics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Macular Degeneration
Figure 11. Global Macular Degeneration Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Diabetic Retinopathy
Figure 13. Global Diabetic Retinopathy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Diabetic Macular Edema
Figure 15. Global Diabetic Macular Edema Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Uveitis
Figure 17. Global Uveitis Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Global Retinal Biologics Market Size Share by Type: 2022 & 2033
Figure 21. North America Retinal Biologics Revenue Market Share by Type (2018-2033)
Figure 22. Europe Retinal Biologics Revenue Market Share by Type (2018-2033)
Figure 23. Asia-Pacific Retinal Biologics Revenue Market Share by Type (2018-2033)
Figure 24. Latin America Retinal Biologics Revenue Market Share by Type (2018-2033)
Figure 25. Middle East and Africa Retinal Biologics Revenue Market Share by Type (2018-2033)
Figure 26. Hospitals Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Clinics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 29. Global Retinal Biologics Market Size Share by Application: 2022 & 2033
Figure 30. North America Retinal Biologics Revenue Market Share by Application (2018-2033)
Figure 31. Europe Retinal Biologics Revenue Market Share by Application (2018-2033)
Figure 32. Asia-Pacific Retinal Biologics Revenue Market Share by Application (2018-2033)
Figure 33. Latin America Retinal Biologics Revenue Market Share by Application (2018-2033)
Figure 34. Middle East and Africa Retinal Biologics Revenue Market Share by Application (2018-2033)
Figure 35. Retinal Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Retinal Biologics Market Share in 2022
Figure 37. North America Retinal Biologics Market Share by Country (2018-2033)
Figure 38. U.S. Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 39. Canada Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 40. Germany Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 41. France Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 42. U.K. Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 43. Italy Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 44. Russia Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 45. Nordic Countries Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 46. Asia-Pacific Retinal Biologics Market Share by Region (2018-2033)
Figure 47. China Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 48. Japan Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 49. South Korea Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 51. India Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 52. Australia Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 53. Latin America Retinal Biologics Market Share by Country (2018-2033)
Figure 54. Mexico Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 55. Brazil Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 56. Middle East & Africa Retinal Biologics Market Share by Country (2018-2033)
Figure 57. Turkey Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 59. UAE Retinal Biologics Market Size (2018-2033) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report